Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner

Chinese Medical Sciences Journal

Volumn 21, Issue 4, 2006, Pages 214-218

  Hu, Ling ^a   Yue, Yun ^b   Zuo, Ping Ping ^b   Jin, Zheng Yu ^a   Feng, Feng ^a   You, Hui ^a   Li, Ming Li ^a   Ge, Qin Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apolipoprotein E; Estrogen; Hippocampus; Long term low dose hormone replacement therapy; Magnetic resonance spectroscopy

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; ESTROGEN; PROGESTERONE; TESTOSTERONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; HIPPOCAMPUS; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E3; ASPARTIC ACID; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; TESTOSTERONE;

EID: 33846345786     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Judd HL, Judd GE, Lucas WE, et al. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974; 39:1024-4.
2. Whitehouse P. MCI and Alzheimer's disease: different conditions or diagnostic confusion? Psychiatr Times 2004; 2:87-9
3. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 1997; 388:507-25
4. Peiersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-92.
5. Squire LT, Zola-Morgan S. The medial temporal lobe memory system. Science 1991; 253:1380-6.
6. Feldman H, Gauthier S, Hecker J, et al. A 24-week, random-ized, double-blind study of donepezil in moderate to severe Alzheimer's disease Neurology 2001; 57:613-20.
7. Shughrue PJ, Scrimo PJ, Merchenthaler I, et al. Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain. Neuroscience 2000; 96:41-9.
8. Luine V. Estradiol increases choline acetyl-transferase activity in specific basal forebrain nuclei and profuction areas of female rats. Exp Neurol 1985; 89:484-90.
9. Pike CJ. Estrogen modulates neuronal Bcl-xI expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 1999; 72:1552-63.
10. Behl C, Skutella T, Lezoualch F, et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997; 51:535-41.
11. Petanceska SS, Nagy G, Frail D, et al. Ovariectomy and 17 β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Neurology 2000; 54:2212-7.
12. Jeffrey RP, Edward CR, Murali PD. Neuroimaging and early-diagnosis of Alzheimer disease: a look to the future. Radiology 2003; 226:315-36.
13. Jellinger K. Morphology of Alzheimer disease and related disorders. New York: Springer-Velag; 1990. p. 61-77.
14. Corder EH, Huarig R, Catheart HM, et al. Membership in genetic groups predicts Alzheimier disease. Rejuvenation Res 2006; 9:89-93.
15. Persson J, Lind J, Larsson A, et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 2006; 66:1029-33.